Search Results - "E, Cocco"

An overall view of the most common experimental models for multiple sclerosis by Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., Fadda, P.

“…Multiple sclerosis (MS) is a complex chronic disease with an unknown etiology. It is considered an inflammatory demyelinating and neurodegenerative disorder of…”
Get full text

Spinal cord MRI activity in multiple sclerosis: Predictive value for relapses and impact on treatment decisions by Lorefice, L., Piras, C., Sechi, V., Barracciu, M.A., Cocco, E., Fenu, G.

“…Emerging evidence suggests the prognostic value of spinal cord (SC) pathology in multiple sclerosis (MS). However, the 2021 MAGNIMS-CMSC-NAIMS guidelines don't…”
Get full text

Clinical activity after fingolimod cessation: disease reactivation or rebound? by Frau, J., Sormani, M. P., Signori, A., Realmuto, S., Baroncini, D., Annovazzi, P., Signoriello, E., Maniscalco, G. T., La Gioia, S., Cordioli, C., Frigeni, B., Rasia, S., Fenu, G., Grasso, R., Sartori, A., Lanzillo, R., Stromillo, M. L., Rossi, S., Forci, B., Cocco, E.

“…Background and purpose There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether…”
Get full text

How to measure the treatment response in progressive multiple sclerosis: Current perspectives and limitations in clinical settings by Lorefice, L., Mellino, P., Fenu, G., Cocco, E.

“…•In the current therapeutic scenario, new drugs are available for patients with progressively active MS.•The review critically analyzes the current measures to…”
Get full text

Evolution of teriflunomide use in multiple sclerosis: A real-world experience by Lorefice, L., Pilotto, S., Fenu, G., Cimino, P., Firinu, D., Frau, J., Murgia, F., Coghe, G., Cocco, E.

“…The present study aims to describe the evolution of teriflunomide use for multiple sclerosis (MS) in the clinical setting, in particular for naïve patients and…”
Get full text

Assessing the role of agri-environmental measures to enhance the environment in the Veneto Region, Italy, with a model-based approach by Dal Ferro, N., Cocco, E., Lazzaro, B., Berti, A., Morari, F.

“…⿢Agri-environmental measures improve the environment in the Veneto Region, Italy.⿢Agroecosystems benefit from the adoption of continuous soil cover and minimal…”
Get full text

Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperium by Caria, P., Pilotto, S., D'Alterio, M.N., Fronza, M., Murgia, F., Frau, J., Fenu, G., Dettori, T., Frau, D.V., Atzori, L., Angioni, S., Cocco, E., Lorefice, L.

“…Several studies indicated leukocyte telomere length (LTL) as a biomarker of multiple sclerosis (MS) evolution. This study aimed to investigate LTL in women…”
Get full text

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers by Fenu, G, Fronza, M, Lorefice, L, Arru, M, Coghe, G, Frau, J, Marrosu, M G, Cocco, E

“…The relationship between cognitive assessment results in multiple sclerosis (MS) and performance in daily activities (DAs) remains unclear. Our study aimed to…”
Get full text

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine by Signoriello, E., Foschi, M., Lanzillo, R., Frau, J., Cocco, E., Borriello, G., Ianniello, A., Trotta, M., Landi, D., Maniscalco, G. T., Ruscica, F., Toscano, S., Patti, F., Zanghì, A., D’Amico, E., Fantozzi, R., Centonze, D., Lus, G., Bonavita, S.

“…Introduction C ladribine is an oral immune reconstitution therapy for relapsing multiple sclerosis (RMS). Hormonal and immune changes are responsible for the…”
Get full text

How shallow water table conditions affect N2O emissions and associated microbial abundances under different nitrogen fertilisations by Cocco, E., Bertora, C., Squartini, A., Delle Vedove, G., Berti, A., Grignani, C., Lazzaro, B., Morari, F.

“…•N2O emissions increased after fertilisation and remained elevated for 2–3 weeks.•Daily emissions were affected by water-filled pore space.•Size of nitrifying…”
Get full text

‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis by Lorefice, Lorena, Coghe, G., Fenu, G., Porta, M., Pilloni, G., Frau, J., Corona, F., Sechi, V., Barracciu, M. A., Marrosu, M. G., Pau, M., Cocco, E.

“…Motor and cognitive disabilities are related to brain atrophy in multiple sclerosis (MS). ‘Timed up and go’ (TUG) has been recently tested in MS as functional…”
Get full text

Multidimensional frailty and its association with quality of life and disability: A cross-sectional study in people with multiple sclerosis by Frau, J, Mulasso, A, Coghe, G, Melis, M, Beratto, L, Cuomo, S, Lorefice, L, Fenu, G, Cocco, E

“…People with multiple sclerosis (pwMS) have a high risk of frailty. We aim to evaluate frailty using the Tilburg frailty indicator (TFI), a multidimensional…”
Get full text

Genetic Fusarium chemotyping as a useful tool for predicting nivalenol contamination in winter wheat by Pasquali, M., Giraud, F., Brochot, C., Cocco, E., Hoffmann, L., Bohn, T.

“…Fusarium graminearum [teleomorph Gibberella zeae] and Fusarium culmorum together with Fusarium poae are the main species known to produce nivalenol (NIV). The…”
Get full text

Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives by Lorefice, Lorena, D'Alterio, Maurizio Nicola, Firinu, Davide, Fenu, Giuseppe, Cocco, Eleonora

“…Given the aging population, with a peak age-specific prevalence that is shifting beyond the age of 50, several women currently living with MS are very close to…”
Get full text

The risk of Bipolar Disorders in Multiple Sclerosis by Carta, M.G, Moro, M.F, Lorefice, L, Trincas, G, Cocco, E, Giudice, E. Del, Fenu, G, Colom, F, Marrosu, M.G

“…Abstract Background The aim was to determine the risk of Mood Disorders (MD), particularly Bipolar Disorders (BD), in Multiple Sclerosis (MS) using…”
Get full text

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey by Lavorgna, L., Esposito, S., Lanzillo, R., Sparaco, M., Ippolito, D., Cocco, E., Fenu, G., Borriello, G., De Mercanti, S., Frau, J., Capuano, R., Trojsi, F., Rosa, L., Clerico, M., Laroni, A., Morra, V. Brescia, Tedeschi, G., Bonavita, S.

“…Background Little is known about the influence of multiple sclerosis (MS) diagnosis on parenthood attitude in people with MS (pwMS). Objective To investigate…”
Get full text

Multiple sclerosis severity score : Using disability and disease duration to rate disease severity by ROXBURGH, R. H. S. R, SEAMAN, S. R, EDAN, G, MCDONNELL, G. V, HAWKINS, S, TROJANO, M, LIGUORI, M, COCCO, E, MARROSU, M. G, TESSER, F, LEONE, M. A, WEBER, A, MASTERMAN, T, ZIPP, F, MITERSKI, B, EPPLEN, J. T, OTURAI, A, SOELBERG SØRENSEN, P, CELIUS, E. G, TELLEZ LARA, N, MONTALBAN, X, VILLOSLADA, P, SILVA, A. M, HENSIEK, A. E, MARTA, M, LEITE, I, DUBOIS, B, RUBIO, J, BUTZKUEVEN, H, KILPATRICK, T, MYCKO, M. P, SELMAJ, K. W, RIO, M. E, SA, M, SAWCER, S. J, SALEMI, G, SAVETTIERI, G, HILLERT, J, COMPSTON, D. A. S, VUKUSIC, S, ACHITI, I, CONFAVREUX, C, COUSTANS, M, LE PAGE, E

“…There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single…”
Get full text

Walking improvements with nabiximols in patients with multiple sclerosis by Coghe, G., Pau, M., Corona, F., Frau, J., Lorefice, L., Fenu, G., Spinicci, G., Mamusa, E., Musu, L., Massole, S., Massa, R., Marrosu, M. G., Cocco, E.

“…Recently, nabiximols was approved as a treatment in MS spasticity. Data leading to approval and clinical use of nabiximols, although widely recognised, are…”
Get full text

Cognition in multiple sclerosis: Between cognitive reserve and brain volume by Fenu, G., Lorefice, L., Arru, M., Sechi, V., Loi, L., Contu, F., Cabras, F., Coghe, G., Frau, J., Fronza, M., Sbrescia, G., Lai, V., Boi, M., Mallus, S., Murru, S., Porcu, A., Barracciu, M.A., Marrosu, M.G., Cocco, E.

“…Several correlations between cognitive impairment (CI), radiologic markers and cognitive reserve (CR) have been documented in MS. To evaluate correlation…”
Get full text

Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment by Frau, J., Coghe, G., Casanova, P., Sardu, C., Lorefice, L., Fenu, G., Marrosu, M. G., Cocco, E.

“…Background and purpose Patients with multiple sclerosis (MS) have many pregnancy‐related doubts and fears. Careful counselling is thus important. Mitoxantrone…”
Get full text